Table of Contents
PharmSights
| Focus on α4β2* and α6β2* nAChRs for Parkinson’s Disease Therapeutics |
Abstract PDF |
| Xiomara A Pérez, Maryka Quik |
1-6 |
| Molecular Pharmacological Approach Reveals Potential New Strategies to Suppress Androgen Receptor Signaling in Prostate Cancer |
Abstract PDF |
| Tetsuo Mashima, Sachiko Okabe, Hiroyuki Seimiya |
7-12 |
| STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic Agents |
Abstract PDF |
| Sarah R Walker, Mousumi Chaudhury, David A Frank |
13-19 |
Research Articles
| Evaluation of Anticancer Properties of Medicinal Plants from the Indian Sub-Continent |
Abstract PDF |
| Akbar Nawab, Mohammad Yunus, Abbas A Mahdi, Sanjay Gupta |
21-29 |
Reviews
| Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis |
Abstract PDF |
| Shi-Yong Sun |
31-34 |
FDA Corner
| FDA Approves Edarbi to Treat High Blood Pressure |
Abstract PDF |
| |
35 |
| FDA Approves Drug to Reduce Risk of Preterm Birth in At-risk Pregnant Women |
Abstract PDF |
| |
35-36 |
| FDA Approves Viibryd to Treat Major Depressive Disorder |
Abstract PDF |
| |
36 |
| FDA Approves Head Lice Treatment for Children and Adults |
Abstract PDF |
| |
36-37 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
